| |
|
|
|
scPharmaceuticals Inc.  
|
|
5.29 -0.22 (-0.04%) |
11-12 16:00 |
|
Open: |
5.366 |
Pre close: |
5.51 |
Target:
|
6.72 
|
|
High: |
5.61 |
Low: |
5.16 |
Resistance:
|
5.75
6.46
|
|
Volume: |
13,694 |
Market Cap: |
98M |
Support:
|
4.61
3.84
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.22
|
MACD |
MACD(12,26):
|
-0.15  |
|
MA(20): |
5.52 |
Signal(12,26,9): |
-0.16 |
|
MA(100): |
5.47 |
Stochastic Oscillator |
%K(14,3):
|
51.30 |
|
MA(250): |
4.36 |
%D(3): |
40.26 |
|
Average Volume(K) |
3-Month: |
4732
|
52-Week |
High:
|
7.85 |
|
10-Days: |
2864 |
Low: |
2.44 |
|
RSI |
RSI(14):
|
45.90 |
Change(%): |
3.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.450 |
Return on Equity (ttm) |
-35.3 |
Shares Out. (M) |
18.58 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.1 |
Shares Float (M) |
11.81 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
77.16 |
|
Forward EPS |
-2.159 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
50 |
|
Book Value (p.s.) |
3.420 |
EBITDA (p.s.) |
-1.390 |
P/E |
-3.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.55 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-21.30 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.49 |
P/CF |
-4.61 |
|
|
|
|
|
|
